Share
11 months ago
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
11 months ago
FDA Approves World's First Crispr Gene-Editing Drug for Sickle-Cell Disease
11 months ago
US regulators approve two gene therapies for sickle cell disease
11 months ago
US approves CRISPR gene-editing to treat sickle cell disease
Tags: CRISPR gene-editing, gene therapies, Casgevy, treatment, U.S., regulators, sickle cell disease, FDA Approves World, First Crispr Gene-Editing Drug, US, Sickle-Cell Disease,
Enter your email to subscribe to news alerts
Subscribe
←Top Latest Headlines